KEYTRUDA[ticker: KEYTRUDA]
livebuyback & burnlaunched —by 7f6h…EoQk
price
$0.00000230
market cap
24h change
vol 24h
—
traders 24h
—
market cap
bonding curve0.40.4 %0.10 SOL0.10 SOL raisedgraduates to pumpswap when the curve completes
thesis
live
about
Moderna and Merck announced positive results from the Phase 3 INTerpath-001 trial, where their personalized mRNA vaccine intismeran autogene combined with KEYTRUDA beat KEYTRUDA alone for high-risk melanoma patients.
your position
connect a wallet to track your position.